Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice

Emerging Trends in Drugs, Addictions, and Health · Elsevier

Аннотация

Publication date: 1 February 2027 Source: Neuropharmacology, Volume 303 Author(s): Sara M. Herz, Abrar M. Khan, Isis Betancourt-Toscano, Caleb G. Tiron, Viviane N. Ton, Dana E. Selley, M. Imad Damaj

Читать у издателя →

Похожие статьи